| Michel Fernandez, MD | |
|
2000 Health Park Dr, Brentwood, TN 37027-4525 | |
| (615) 372-5068 | |
| Not Available |
| Full Name | Michel Fernandez |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 2000 Health Park Dr, Brentwood, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477717841 | NPI | - | NPPES |
| 197425501 | Medicaid | TX | |
| 8X9566 | Other | TX | BCBS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Jacksonville | Jacksonville, FL | Hospital |
| Orange Park Medical Center | Orange park, FL | Hospital |
| Baptist Medical Center Beaches | Jacksonville beach, FL | Hospital |
| Entity Name | Intensive Care Consortium Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629019062 PECOS PAC ID: 0244269413 Enrollment ID: O20050808000883 |
News Archive
A blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells seems to occur even after a two-month break from boxing. This is shown in a new study from the Sahlgrenska Academy, University of Gothenburg, Sweden.
The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.
With chronic diseases on the rise in children, pediatricians are looking for solutions to improve care and outcomes for these often complex illnesses. The American Academy of Pediatrics (AAP) today announced a new initiative funded with a grant from the Merck Childhood Asthma Network, Inc. (MCAN) that will allow pediatricians across the country to pilot a series of quality improvement programs to effectively address the top chronic disease affecting kids - childhood asthma.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Although Kenya has recorded a decrease in HIV/AIDS prevalence from 6.1% to 5.9% during the past year, the country's HIV/AIDS control efforts could be undermined by delays in funding disbursement and other challenges, the Lancet reports.
› Verified 4 days ago
| Entity Name | Respiratory Critical Care And Sleep Medicine Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386622629 PECOS PAC ID: 3971602970 Enrollment ID: O20070615000138 |
News Archive
A blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells seems to occur even after a two-month break from boxing. This is shown in a new study from the Sahlgrenska Academy, University of Gothenburg, Sweden.
The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.
With chronic diseases on the rise in children, pediatricians are looking for solutions to improve care and outcomes for these often complex illnesses. The American Academy of Pediatrics (AAP) today announced a new initiative funded with a grant from the Merck Childhood Asthma Network, Inc. (MCAN) that will allow pediatricians across the country to pilot a series of quality improvement programs to effectively address the top chronic disease affecting kids - childhood asthma.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Although Kenya has recorded a decrease in HIV/AIDS prevalence from 6.1% to 5.9% during the past year, the country's HIV/AIDS control efforts could be undermined by delays in funding disbursement and other challenges, the Lancet reports.
› Verified 4 days ago
| Entity Name | Michel Fernandez Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497337422 PECOS PAC ID: 6204233463 Enrollment ID: O20210930002022 |
News Archive
A blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells seems to occur even after a two-month break from boxing. This is shown in a new study from the Sahlgrenska Academy, University of Gothenburg, Sweden.
The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.
With chronic diseases on the rise in children, pediatricians are looking for solutions to improve care and outcomes for these often complex illnesses. The American Academy of Pediatrics (AAP) today announced a new initiative funded with a grant from the Merck Childhood Asthma Network, Inc. (MCAN) that will allow pediatricians across the country to pilot a series of quality improvement programs to effectively address the top chronic disease affecting kids - childhood asthma.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Although Kenya has recorded a decrease in HIV/AIDS prevalence from 6.1% to 5.9% during the past year, the country's HIV/AIDS control efforts could be undermined by delays in funding disbursement and other challenges, the Lancet reports.
› Verified 4 days ago
| Entity Name | Blueapplecare, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245892611 PECOS PAC ID: 8224403142 Enrollment ID: O20230406002082 |
News Archive
A blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells seems to occur even after a two-month break from boxing. This is shown in a new study from the Sahlgrenska Academy, University of Gothenburg, Sweden.
The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.
With chronic diseases on the rise in children, pediatricians are looking for solutions to improve care and outcomes for these often complex illnesses. The American Academy of Pediatrics (AAP) today announced a new initiative funded with a grant from the Merck Childhood Asthma Network, Inc. (MCAN) that will allow pediatricians across the country to pilot a series of quality improvement programs to effectively address the top chronic disease affecting kids - childhood asthma.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Although Kenya has recorded a decrease in HIV/AIDS prevalence from 6.1% to 5.9% during the past year, the country's HIV/AIDS control efforts could be undermined by delays in funding disbursement and other challenges, the Lancet reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michel Fernandez, MD 100 Broadbranch Way, Saint Johns, FL 32259-7212 Ph: (817) 907-9550 | Michel Fernandez, MD 2000 Health Park Dr, Brentwood, TN 37027-4525 Ph: (615) 372-5068 |
News Archive
A blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells seems to occur even after a two-month break from boxing. This is shown in a new study from the Sahlgrenska Academy, University of Gothenburg, Sweden.
The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.
With chronic diseases on the rise in children, pediatricians are looking for solutions to improve care and outcomes for these often complex illnesses. The American Academy of Pediatrics (AAP) today announced a new initiative funded with a grant from the Merck Childhood Asthma Network, Inc. (MCAN) that will allow pediatricians across the country to pilot a series of quality improvement programs to effectively address the top chronic disease affecting kids - childhood asthma.
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Although Kenya has recorded a decrease in HIV/AIDS prevalence from 6.1% to 5.9% during the past year, the country's HIV/AIDS control efforts could be undermined by delays in funding disbursement and other challenges, the Lancet reports.
› Verified 4 days ago
Larry J Pharris, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2087 Fax: 629-255-4103 | |
Carla Fridman, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 105 Westwood Pl Ste 400, Brentwood, TN 37027 Phone: 954-300-2151 | |
Dr. Kavita Singh Karlekar, MD, FAAP Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1607 Westgate Circle, Suite 200, Brentwood, TN 37027 Phone: 615-376-8195 | |
Julie A Hendrix, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2113 Fax: 629-255-4109 | |
Donna D Scudder, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2181 Fax: 629-255-4031 | |
Archana Kochar Mehta, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1247 Monarch Way, Brentwood, TN 37027 Phone: 615-396-4694 Fax: 615-396-6751 | |
Francis J Caprio, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1622 Westgate Cir, Brentwood, TN 37027 Phone: 629-255-2083 Fax: 629-255-4101 |